Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY
NEW YORK, January 10, 2026, 10:08 EST — Market closed Eli Lilly & Co shares fell 2% on Friday to $1,063.56, underperforming a stronger broader market and extending a two-day slide. The stock is now 6.21% below its 52-week high of $1,133.95 set on Thursday, while trading volume ran below its recent average. The pullback lands as investors re-price big…